Thermo Fisher Scientific Inc (TMO):企業の財務・戦略的SWOT分析

◆英語タイトル:Thermo Fisher Scientific Inc (TMO) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1581
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:92
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Thermo Fisher Scientific Inc (TMO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Thermo Fisher Scientific Inc (Thermo Fisher) provides equipment, analytical instruments, reagents and consumables, software and services to tackle complex analytical challenges in research, diagnostics and clinical laboratories. It offers solutions for cellular analysis and biology, flow cytometry and synthetic biology. The company’s product portfolio includes technologies for mass spectrometry, electron microscopy, genetic sequencing, protein and molecular biology research. The company serves pharmaceutical and biotech companies, academic and research institutions, clinical diagnostic labs, and government agencies; and environmental, industrial quality and process control sectors. It sells its products and services through direct sales force, e-commerce and third-party distributors in the Americas, Asia-Pacific and Europe. Thermo Fisher is headquartered in Waltham, Massachusetts, the US.

Thermo Fisher Scientific Inc Key Recent Developments

Apr 24,2020 Thermo Fisher Scientific and Hamilton Company introduce forensic laboratory-qualified automated nucleic acid extraction platform
Apr 22,2020 Thermo Fisher Scientific reports first quarter 2020 results
Apr 06,2020 Thermo Fisher Scientific provides COVID-19 business update and will hold first quarter earnings conference call on Wednesday, April 22, 2020
Apr 01,2020 Thermo Fisher Scientific launches quality control for Covid-19 tests

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Thermo Fisher Scientific Inc – Key Facts
Thermo Fisher Scientific Inc – Key Employees
Thermo Fisher Scientific Inc – Key Employee Biographies
Thermo Fisher Scientific Inc – Major Products and Services
Thermo Fisher Scientific Inc – History
Thermo Fisher Scientific Inc – Company Statement
Thermo Fisher Scientific Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Thermo Fisher Scientific Inc – Business Description
Product Category: Consumables
Performance
Product Category: Instruments
Performance
Product Category: Services
Performance
Product Category: Analytical Instruments
Overview
Performance
Key Stats
Product Category: Laboratory Products and Services
Overview
Performance
Key Stats
Product Category: Life Sciences Solutions
Overview
Performance
Key Stats
Product Category: Specialty Diagnostics
Overview
Performance
Key Stats
Geographical Segment: China
Performance
Geographical Segment: Other
Performance
Geographical Segment: United States
Performance
R&D Overview
Thermo Fisher Scientific Inc – Corporate Strategy
Thermo Fisher Scientific Inc – SWOT Analysis
SWOT Analysis – Overview
Thermo Fisher Scientific Inc – Strengths
Thermo Fisher Scientific Inc – Weaknesses
Thermo Fisher Scientific Inc – Opportunities
Thermo Fisher Scientific Inc – Threats
Thermo Fisher Scientific Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Oil & Gas Financial Deals and Alliances
Thermo Fisher Scientific Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Thermo Fisher Scientific Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Thermo Fisher Scientific Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 24, 2020: Thermo Fisher Scientific and Hamilton Company introduce forensic laboratory-qualified automated nucleic acid extraction platform
Apr 22, 2020: Thermo Fisher Scientific reports first quarter 2020 results
Apr 06, 2020: Thermo Fisher Scientific provides COVID-19 business update and will hold first quarter earnings conference call on Wednesday, April 22, 2020
Apr 01, 2020: Thermo Fisher Scientific launches quality control for Covid-19 tests
Mar 31, 2020: New-generation analytical platform accelerates analysis of trace elements for routine laboratory applications
Mar 25, 2020: Italian researchers identify new SARS-CoV-2 gene variants that provide clues to coronavirus’s epidemiology
Mar 23, 2020: Thermo Fisher Scientific Continues Investments to Accelerate Biopharma Commercialization
Mar 20, 2020: UC San Diego partners with 5 leading diagnostics manufacturers to boost COVID-19 Testing
Mar 13, 2020: Thermo Fisher, Janssen partner to develop CDx for oncology
Mar 12, 2020: Thermo Fisher Scientific signs agreement with Janssen to co-develop Companion Diagnostic for Cancer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Thermo Fisher Scientific Inc, Key Facts
Thermo Fisher Scientific Inc, Key Employees
Thermo Fisher Scientific Inc, Key Employee Biographies
Thermo Fisher Scientific Inc, Major Products and Services
Thermo Fisher Scientific Inc, History
Thermo Fisher Scientific Inc, Subsidiaries
Thermo Fisher Scientific Inc, Joint Venture
Thermo Fisher Scientific Inc, Key Competitors
Thermo Fisher Scientific Inc, Ratios based on current share price
Thermo Fisher Scientific Inc, Annual Ratios
Thermo Fisher Scientific Inc, Annual Ratios (Cont...1)
Thermo Fisher Scientific Inc, Annual Ratios (Cont...2)
Thermo Fisher Scientific Inc, Interim Ratios
Thermo Fisher Scientific Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Thermo Fisher Scientific Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Thermo Fisher Scientific Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Thermo Fisher Scientific Inc, Performance Chart (2015 - 2019)
Thermo Fisher Scientific Inc, Ratio Charts
Thermo Fisher Scientific Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Thermo Fisher Scientific Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Thermo Fisher Scientific Inc (TMO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hertz Global Holdings Inc:企業の戦略・SWOT・財務情報
    Hertz Global Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Hertz Global Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Golden Ocean Group Limited:企業のM&A・事業提携・投資動向
    Golden Ocean Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Golden Ocean Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Monsanto Co (MON):企業の財務・戦略的SWOT分析
    Monsanto Co (MON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Orange SA:企業の戦略・SWOT・財務情報
    Orange SA - Strategy, SWOT and Corporate Finance Report Summary Orange SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Avantium NV (AVTX):企業の財務・戦略的SWOT分析
    Avantium NV (AVTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Merit Medical Systems Inc (MMSI):企業の財務・戦略的SWOT分析
    Merit Medical Systems Inc (MMSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Amgen, Inc.:企業のM&A・事業提携・投資動向
    Amgen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amgen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Komatsu Ltd.:企業の戦略・SWOT・財務分析
    Komatsu Ltd. - Strategy, SWOT and Corporate Finance Report Summary Komatsu Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • DJO Global Inc:医療機器:M&Aディール及び事業提携情報
    Summary DJO Global Inc. (DJO) is a medical device company. The company engages in provision of orthopaedic devices. DIO develops, manufactures and distributors orthopaedic devices for musculoskeletal health, vascular health and pain management solutions. The company products include rigid and soft o …
  • Verint Systems Inc. (VRNT):企業の財務・戦略的SWOT分析
    Verint Systems Inc. (VRNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Oceaneering International Inc (OII):石油・ガス:M&Aディール及び事業提携情報
    Summary Oceaneering International Inc (Oceaneering) is an oilfield provider of engineered products and services. The company serves primarily the offshore oil and gas industry, with a focus on deepwater applications. Its oilfield products and services include remotely operated vehicles, specialty su …
  • Hang Seng Bank Ltd:企業の戦略・SWOT・財務情報
    Hang Seng Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Hang Seng Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Keryx Biopharmaceuticals Inc (KERX)-製薬・医療分野:企業M&A・提携分析
    Summary Keryx Biopharmaceuticals Inc (Keryx) develops and commercializes new therapies for the treatment of renal disease. The company’s lead product Auryxia (ferric citrate) is an FDA approved oral, absorbable iron-based phosphate binder, which helps lower the amount of phosphate in human blood. Au …
  • Kineta Inc-製薬・医療分野:企業M&A・提携分析
    Summary Kineta Inc (Kineta) is a biotech company that develops novel immuno-therapies. The company offers small-molecule compounds that target RIG-I-like receptor pathways and intracellular IRF3-inducing pathways for applications in cancer. Its KCP-400 is a novel non-opioid therapy for the treatment …
  • Fomento de Construcciones y Contratas S.A.:企業の戦略・SWOT・財務分析
    Fomento de Construcciones y Contratas S.A. - Strategy, SWOT and Corporate Finance Report Summary Fomento de Construcciones y Contratas S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Maruti Suzuki India Limited:企業の戦略・SWOT・財務情報
    Maruti Suzuki India Limited - Strategy, SWOT and Corporate Finance Report Summary Maruti Suzuki India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Exelixis Inc (EXEL):製薬・医療:M&Aディール及び事業提携情報
    Summary Exelixis Inc (Exelixis) is a biopharmaceutical company that focuses on the development and commercialization of small molecule therapies for the treatment of cancer. The company has three product candidates: Cometriq (Cabozantinib), an inhibitor of multiple receptor tyrosine kinases; Cabomet …
  • Covance Inc-製薬・医療分野:企業M&A・提携分析
    Summary Covance Inc (Covance), a subsidiary of LabCorp, is a drug development company that offers contract research and manufacturing services. The company offers a broad range of early-stage and late-stage product development services to pharmaceutical, biotechnology and medical device companies. I …
  • CanBas Co Ltd (4575):製薬・医療:M&Aディール及び事業提携情報
    Summary CanBas Co Ltd (CanBas) is a clinical stage biopharmaceutical company that develops therapeutics for cancer. The company discovers and develops of novel therapeutics in the field of oncology targeting the cell cycle. It provides two clinical oncology programs, CBP501 and CBS9106 with mutually …
  • Arup Group Ltd:企業の戦略的SWOT分析
    Arup Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆